BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22044354)

  • 1. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
    Hinske LC; Weis F; Heyn J; Hinske P; Beiras-Fernandez A
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):1-7. PubMed ID: 22044354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activity of micafungin].
    Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
    Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of micafungin against Candida biofilms].
    Quindós G; Villar-Vidal M; Eraso E
    Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echinocandins in children].
    Leverger G; Le Guyader N
    Arch Pediatr; 2011 May; 18 Suppl 1():S33-41. PubMed ID: 21596285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinocandins--new antifungal agents.
    Stan CD; Tuchiluş C; Stan CI
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin - the newest echinocandin.
    Temesgen Z; Barreto J; Vento S
    Drugs Today (Barc); 2009 Jun; 45(6):469-78. PubMed ID: 19856528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Echinocandins].
    Cortés L JA; Russi N JA
    Rev Chilena Infectol; 2011 Dec; 28(6):529-36. PubMed ID: 22286675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
    Martín Mazuelos E; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():7-13. PubMed ID: 19572429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
    Catalán-González M; Carlos Montejo-González J
    Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
    Lockhart SR; Zimbeck AJ; Baddley JW; Marr KA; Andes DR; Walsh TJ; Kauffman CA; Kontoyiannis DP; Ito JI; Pappas PG; Chiller T
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3944-6. PubMed ID: 21670187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.